581 related articles for article (PubMed ID: 27768909)
1. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
Mock K; Lateef S; Benedito VA; Tou JC
J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
[TBL] [Abstract][Full Text] [Related]
2. Impact of perinatal exposure to sucrose or high fructose corn syrup (HFCS-55) on adiposity and hepatic lipid composition in rat offspring.
Toop CR; Muhlhausler BS; O'Dea K; Gentili S
J Physiol; 2017 Jul; 595(13):4379-4398. PubMed ID: 28447343
[TBL] [Abstract][Full Text] [Related]
3. Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex-specific manner.
Bhat SF; Pinney SE; Kennedy KM; McCourt CR; Mundy MA; Surette MG; Sloboda DM; Simmons RA
J Physiol; 2021 Mar; 599(5):1487-1511. PubMed ID: 33450094
[TBL] [Abstract][Full Text] [Related]
4. The effect of maternal intake of sucrose or high-fructose corn syrup (HFCS)-55 during gestation and lactation on lipogenic gene expression in rat offspring at 3 and 12 weeks of age.
Kaur H; Toop CR; Muhlhausler BS; Gentili S
J Dev Orig Health Dis; 2018 Oct; 9(5):481-486. PubMed ID: 29909805
[TBL] [Abstract][Full Text] [Related]
5. Comparing the effects of sucrose and high-fructose corn syrup on lipid metabolism and the risk of cardiovascular disease in male rats.
Sadowska J; Bruszkowska M
Acta Sci Pol Technol Aliment; 2017; 16(2):231-240. PubMed ID: 28703963
[TBL] [Abstract][Full Text] [Related]
6. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults.
Stanhope KL; Medici V; Bremer AA; Lee V; Lam HD; Nunez MV; Chen GX; Keim NL; Havel PJ
Am J Clin Nutr; 2015 Jun; 101(6):1144-54. PubMed ID: 25904601
[TBL] [Abstract][Full Text] [Related]
7. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
8. Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults.
Sigala DM; Hieronimus B; Medici V; Lee V; Nunez MV; Bremer AA; Cox CL; Price CA; Benyam Y; Chaudhari AJ; Abdelhafez Y; McGahan JP; Goran MI; Sirlin CB; Pacini G; Tura A; Keim NL; Havel PJ; Stanhope KL
J Clin Endocrinol Metab; 2021 Oct; 106(11):3248-3264. PubMed ID: 34265055
[TBL] [Abstract][Full Text] [Related]
9. High-fructose corn syrup-induced hepatic dysfunction in rats: improving effect of resveratrol.
Sadi G; Ergin V; Yilmaz G; Pektas MB; Yildirim OG; Menevse A; Akar F
Eur J Nutr; 2015 Sep; 54(6):895-904. PubMed ID: 25238689
[TBL] [Abstract][Full Text] [Related]
10. The type of caloric sweetener added to water influences weight gain, fat mass, and reproduction in growing Sprague-Dawley female rats.
Light HR; Tsanzi E; Gigliotti J; Morgan K; Tou JC
Exp Biol Med (Maywood); 2009 Jun; 234(6):651-61. PubMed ID: 19359658
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet.
Shimada M; Hibino M; Takeshita A
Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in mice fed a high-caloric diet.
Soto M; Chaumontet C; Even PC; Azzout-Marniche D; Tomé D; Fromentin G
Physiol Behav; 2017 Jun; 175():47-55. PubMed ID: 28347724
[TBL] [Abstract][Full Text] [Related]
13. Consumption of High-Fructose Corn Syrup Compared with Sucrose Promotes Adiposity and Increased Triglyceridemia but Comparable NAFLD Severity in Juvenile Iberian Pigs.
Maj M; Harbottle B; Thomas PA; Hernandez GV; Smith VA; Edwards MS; Fanter RK; Glanz HS; Immoos C; Burrin DG; Santiago-Rodriguez TM; La Frano MR; Manjarín R
J Nutr; 2021 May; 151(5):1139-1149. PubMed ID: 33693900
[TBL] [Abstract][Full Text] [Related]
14. Assessing the effect of sugar type and form of its intake on selected parameters of carbohydrate-lipid metabolism and plasma atherogenic indices in rats.
Sadowska J; Bruszkowska M
Rocz Panstw Zakl Hig; 2019; 70(1):59-67. PubMed ID: 30837747
[TBL] [Abstract][Full Text] [Related]
15. The effect of feeding different sugar-sweetened beverages to growing female Sprague-Dawley rats on bone mass and strength.
Tsanzi E; Light HR; Tou JC
Bone; 2008 May; 42(5):960-8. PubMed ID: 18328797
[TBL] [Abstract][Full Text] [Related]
16. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.
Chung M; Ma J; Patel K; Berger S; Lau J; Lichtenstein AH
Am J Clin Nutr; 2014 Sep; 100(3):833-49. PubMed ID: 25099546
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
[TBL] [Abstract][Full Text] [Related]
18. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
19. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
Zhao X; Xue J; Wang XL; Zhang Y; Deng M; Xie ML
Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
[TBL] [Abstract][Full Text] [Related]
20. Consumption of sucrose, but not high fructose corn syrup, leads to increased adiposity and dyslipidaemia in the pregnant and lactating rat.
Toop CR; Muhlhausler BS; O'Dea K; Gentili S
J Dev Orig Health Dis; 2015 Feb; 6(1):38-46. PubMed ID: 25523154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
